These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7560246)

  • 1. Steady-state pharmacokinetic evaluation of a novel, controlled-release morphine suppository and subcutaneous morphine in cancer pain.
    Bruera E; Fainsinger R; Spachynski K; Babul N; Harsanyi Z; Darke AC
    J Clin Pharmacol; 1995 Jul; 35(7):666-72. PubMed ID: 7560246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation.
    Bruera E; Fainsinger R; Spachynski K; Babul N; Harsanyi Z; Darke AC
    J Clin Oncol; 1995 Jun; 13(6):1520-7. PubMed ID: 7751901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy, safety and pharmacokinetics of a newly developed controlled release morphine sulphate suppository in patients with cancer pain.
    Moolenaar F; Meijler WJ; Frijlink HW; Visser J; Proost JH
    Eur J Clin Pharmacol; 2000 Jun; 56(3):219-23. PubMed ID: 10952476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.
    Gourlay GK
    Clin Pharmacokinet; 1998 Sep; 35(3):173-90. PubMed ID: 9784932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain.
    Gourlay GK; Cherry DA; Onley MM; Tordoff SG; Conn DA; Hood GM; Plummer JL
    Pain; 1997 Feb; 69(3):295-302. PubMed ID: 9085304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients.
    Thirlwell MP; Sloan PA; Maroun JA; Boos GJ; Besner JG; Stewart JH; Mount BM
    Cancer; 1989 Jun; 63(11 Suppl):2275-83. PubMed ID: 2720576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of two novel rectal controlled-release morphine formulations.
    Babul N; Darke AC; Anslow JA; Krishnamurthy TN
    J Pain Symptom Manage; 1992 Oct; 7(7):400-5. PubMed ID: 1484193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MS Contin XL) in cancer pain.
    Hagen NA; Thirlwell M; Eisenhoffer J; Quigley P; Harsanyi Z; Darke A
    J Pain Symptom Manage; 2005 Jan; 29(1):80-90. PubMed ID: 15652441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and safety of controlled-release morphine suppositories and tablets in cancer pain.
    Babul N; Provencher L; Laberge F; Harsanyi Z; Moulin D
    J Clin Pharmacol; 1998 Jan; 38(1):74-81. PubMed ID: 9597563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state kinetics and dynamics of morphine in cancer patients: is sedation related to the absorption rate of morphine?
    Christrup LL; Sjøgren P; Jensen NH; Banning AM; Elbaek K; Ersbøll AK
    J Pain Symptom Manage; 1999 Sep; 18(3):164-73. PubMed ID: 10517037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain.
    Portenoy RK; Sciberras A; Eliot L; Loewen G; Butler J; Devane J
    J Pain Symptom Manage; 2002 Apr; 23(4):292-300. PubMed ID: 11997198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative bioavailability of morphine sulfate and naltrexone hydrochloride extended release capsules (EMBEDA®) and an extended release morphine sulfate capsule formulation (KADIAN®) in healthy adults under fasting conditions.
    Johnson FK; Ciric S; Boudriau S; Kisicki JC; Stauffer J
    Am J Ther; 2011 Jan; 18(1):2-8. PubMed ID: 20864883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivo.
    Morgan DJ; McCormick Y; Cosolo W; Roller L; Zalcberg J
    Int J Clin Pharmacol Ther Toxicol; 1992 Dec; 30(12):576-81. PubMed ID: 1473873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twice-daily versus once-daily morphine sulphate controlled-release suppositories for the treatment of cancer pain. A randomized controlled trial.
    Bruera E; Belzile M; Neumann CM; Ford I; Harsanyi Z; Darke A
    Support Care Cancer; 1999 Jul; 7(4):280-3. PubMed ID: 10423055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study.
    Ridgway D; Sopata M; Burneckis A; Jespersen L; Andersen C
    J Pain Symptom Manage; 2010 Apr; 39(4):712-20. PubMed ID: 20413058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal Pharmacokinetics of Morphine ARER, a Novel Abuse-Deterrent Formulation: Results from a Randomized, Double-Blind, Four-Way Crossover Study in Nondependent, Opioid-Experienced Subjects.
    Webster LR; Pantaleon C; Iverson M; Smith MD; Kinzler ER; Aigner S
    Pain Res Manag; 2018; 2018():7276021. PubMed ID: 29849845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized study of the serum pharmacokinetics of lower thoracic extended-release epidural morphine (DepoDur) after lidocaine-epinephrine test dose administration in patients undergoing upper abdominal surgery.
    Viscusi ER; Manvelian GZ
    Int J Clin Pharmacol Ther; 2009 Nov; 47(11):659-70. PubMed ID: 19840530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
    Dohoo SE; Tasker RA
    Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of morphine in rabbits after rectal administration of suppository containing controlled release morphine tablet.
    Kanamoto I; Zheng NX; Ueno M; Koizumi T; Adachi I; Horikoshi I
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1883-6. PubMed ID: 1394709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic response to single and multiple doses of controlled-release morphine tablets and morphine oral solution in cancer patients.
    Goughnour BR; Arkinstall WW; Stewart JH
    Cancer; 1989 Jun; 63(11 Suppl):2294-7. PubMed ID: 2720578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.